Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the fastest-moving area of American metabolic and longevity medicine. MIAMI, FL, April 28th, 2026, FormBlends, a telehealth platform focused on medically supervised GLP-1 therapy and peptide research, today released its 2026 State of Peptides and GLP-1 Regulation report. The report …






